Merck & Company, Inc.
MRK
Jodie situation report
Merck & Company, Inc.'s move is being confirmed by its market group.
MRK accounts for 23.4% of the group's measured movement across 7.1 effective names. raw member direction is mixed; 0 of 11 SPY-adjusted paths align to the mixed. Capital-flow agreement is 28%, so confirmation is not yet clean. No verified headline preceded the measured group move.
Is this move genuinely shared?
ATRC moved materially before MRK. MRK crossed its material path threshold at 11:20 ET, 50 minutes after the first measured mover. PFE, PBH, RPRX followed.
6 of 11 members in Biopharmaceuticals and Care are active. 0 of 8 disclosed connections are confirming.
- At least 8 of 11 durable members become active together.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as INVA begins moving with the group.
Invalidation: The live read weakens if participation falls to 3 of 11 members or fewer.
Who this business touches
The relationships behind MRK
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
Depended on by
IBRXImmunityBio, Inc.supplierMay 7, 2026 ▾
“This addresses a significant supply challenge: TICE BCG (Merck) has been the sole supplier of BCG product in the U.S.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 34 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
MRK is currently a Participant in the organic co-movement group Biopharmaceuticals and Care. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.